Glecaprevir/Pibrentasvir for 8 Weeks in Treatment-Naïve Patients With Chronic HCV Genotypes 1–6 and Compensated Cirrhosis: The EXPEDITION-8 Trial

Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2019.10.020
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Elsevier BV

Related search

Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection

Advances in Therapy
MedicinePharmacology
2020English

Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: Design, Development, and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)

Health Science Reports
2019English

Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1

Journal of Hepatology
Hepatology
2017English

Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology
MedicineHepatology
2018English

Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology
HepatologyGastroenterology
2019English

Glecaprevir and Pibrentasvir Combination Therapy for Hepatitis C Virus-Infected Japanese Patients on Hemodialysis

Renal Replacement Therapy
2018English

Evaluation of Some Non Invasive Predictors for Presence of Esophageal Varices in Patients With Compensated HCV Positive Cirrhosis

International Journal of Science and Research (IJSR)
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy